These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 2118680)

  • 1. The minimal number of class II MHC-antigen complexes needed for T cell activation.
    Demotz S; Grey HM; Sette A
    Science; 1990 Aug; 249(4972):1028-30. PubMed ID: 2118680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme.
    Brooks A; Hartley S; Kjer-Nielsen L; Perera J; Goodnow CC; Basten A; McCluskey J
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3290-4. PubMed ID: 1707537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation.
    Harding CV; Unanue ER
    Nature; 1990 Aug; 346(6284):574-6. PubMed ID: 2115981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
    Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
    Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High efficiency of endogenous antigen presentation by MHC class II molecules.
    Calin-Laurens V; Forquet F; Lombard-Platet S; Bertolino P; Chrétien I; Trescol-Biémont MC; Gerlier D; Rabourdin-Combe C
    Int Immunol; 1992 Oct; 4(10):1113-21. PubMed ID: 1336977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
    Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
    J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between invariant chain expression level and capability to present antigen to MHC class II-restricted T cells.
    Bertolino P; Forquet F; Pont S; Koch N; Gerlier D; Rabourdin-Combe C
    Int Immunol; 1991 May; 3(5):435-43. PubMed ID: 1655000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells.
    Adorini L; Moreno J; Momburg F; Hämmerling GJ; Guéry JC; Valli A; Fuchs S
    J Exp Med; 1991 Oct; 174(4):945-8. PubMed ID: 1919443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Threshold detection of self-antigen/MHC class II complexes formed in vivo: constitutive presentation of an immunodominant epitope of hen egg lysozyme (HEL) in HEL-transgenic mice.
    Kanost D; Basten A; McCluskey J
    Int Immunol; 1993 Aug; 5(8):893-902. PubMed ID: 8398984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.
    Leighton J; Sette A; Sidney J; Appella E; Ehrhardt C; Fuchs S; Adorini L
    J Immunol; 1991 Jul; 147(1):198-204. PubMed ID: 1711074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell type-specific processing of the I-Ed-restricted hen egg lysozyme determinant 107-116.
    Robadey C; Wallny HJ; Demotz S
    Eur J Immunol; 1996 Jul; 26(7):1656-9. PubMed ID: 8766576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-dominant restriction by a mixed-haplotype I-A molecule (alpha k beta b) for the lysozyme peptide 52-61 in H-2k x H-2b F1 mice.
    Moreno J; Adorini L; Hämmerling GJ
    J Immunol; 1990 May; 144(9):3296-304. PubMed ID: 1970351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self peptide requirement for class II major histocompatibility complex allorecognition.
    Demotz S; Sette A; Sakaguchi K; Buchner R; Appella E; Grey HM
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8730-4. PubMed ID: 1924332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules.
    Nelson CA; Vidavsky I; Viner NJ; Gross ML; Unanue ER
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):628-33. PubMed ID: 9012835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ia-transfected L-cell fibroblasts present a lysozyme peptide but not the native protein to lysozyme-specific T cells.
    Shastri N; Malissen B; Hood L
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5885-9. PubMed ID: 3875853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. IV. Murine T hybridoma cells exhibit differential accessory cell requirements for activation by M. arthritidis T cell mitogen, concanavalin A, or hen egg-white lysozyme.
    Cole BC; Araneo BA; Sullivan GJ
    J Immunol; 1986 May; 136(10):3572-8. PubMed ID: 3486214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient delivery of T cell epitopes to APC by use of MHC class II-specific Troybodies.
    Lunde E; Western KH; Rasmussen IB; Sandlie I; Bogen B
    J Immunol; 2002 Mar; 168(5):2154-62. PubMed ID: 11859101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
    Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ
    J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.